Robert Orenstein, DO

Mayo Clinic

Poster(s):

• E0100 - 24-Month Sustained Clinical Response and Safety of RBX2660 in Participants With Recurrent Clostridioides difficile Infection: Subgroup Analysis
  Tuesday, October 25, 2022

  3:00 PM – 5:00 PM ET